Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$397,811,601
-$16,487,913 QoQ
Shares Held
7,588,928
+1.1% QoQ
Ownership
0.379%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#8
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $19,128,320,487 across 19 Drug Manufacturers - General names. GSK ranks #10 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,358,401 | $5,227,597,337 | |
| 2 | JNJ |
Johnson & Johnson
|
13,211,475 | $3,355,318,297 | |
| 3 | ABBV |
AbbVie Inc.
|
8,163,806 | $2,054,340,133 | |
| 4 | AZN |
Astrazeneca PLC
|
10,427,503 | $1,977,263,112 | |
| 5 | MRK |
Merck & Co., Inc.
|
14,293,086 | $1,836,661,547 | |
| 6 | AMGN |
Amgen Inc
|
4,328,785 | $1,567,539,618 | |
| 7 | PFE |
Pfizer Inc
|
32,814,260 | $790,167,373 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,094,886 | $696,907,326 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $397,811,601 | 7,588,928 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $414,299,514 | 7,506,786 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $415,885,970 | 8,480,546 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $380,832,570 | 8,823,739 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $329,357,448 | 8,577,017 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $293,690,996 | 7,581,079 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $242,462,678 | 7,169,210 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $293,227,697 | 7,172,889 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $271,067,717 | 7,040,720 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $349,279,376 | 8,147,408 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $307,097,202 | 8,286,487 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $292,896,265 | 8,079,897 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $274,072,523 | 7,690,026 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $76,969,851 | 2,163,290 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $64,048,479 | 1,822,666 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $51,337,334 | 1,744,388 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $87,768,604 | 2,055,749 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $88,381,211 | 2,068,672 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $89,956,607 | 2,079,764 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $82,795,297 | 2,209,267 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $80,158,036 | 2,052,416 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $341,542,443 | 9,757,031 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $530,998,093 | 14,711,762 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $574,603,003 | 15,564,595 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $670,891,001 | 16,769,411 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $639,789,578 | 17,215,994 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||